| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2007 | CN1913925A Compositions comprising two different populations of polymer-active agent conjugates |
| 02/14/2007 | CN1913922A Vaginal compositions for treating infections |
| 02/14/2007 | CN1913917A Pharmaceutical composition for thrombin peptide derivatives |
| 02/14/2007 | CN1913911A Physiologically functional drinks and compositions |
| 02/14/2007 | CN1913904A Use of phosphono derivatives as anti-malarials |
| 02/14/2007 | CN1913903A Remedy for external use for skin and mucosal injuries caused by viral infection |
| 02/14/2007 | CN1913902A Treatment of psychoses with dibenzothiazepine antipsychotic |
| 02/14/2007 | CN1913901A Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| 02/14/2007 | CN1913900A Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 02/14/2007 | CN1913899A Anorectic |
| 02/14/2007 | CN1913898A Substituted piperazines |
| 02/14/2007 | CN1913897A Novel compound, corresponding compositions, preparation and/or treatment methods |
| 02/14/2007 | CN1913896A Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1913894A Remedy for hypertension |
| 02/14/2007 | CN1913893A NK-1 receptor antagonists for improving anesthesia recovery |
| 02/14/2007 | CN1913892A Medicinal compositions and combinations |
| 02/14/2007 | CN1913891A Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders |
| 02/14/2007 | CN1913890A Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 02/14/2007 | CN1913889A Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor |
| 02/14/2007 | CN1913888A Methods for reducing the effects of stress on skin condition |
| 02/14/2007 | CN1913887A Combination of voriconazole and an antifungal CYP2C19 inhibitor |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1913885A 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/14/2007 | CN1913883A Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD |
| 02/14/2007 | CN1913882A Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids |
| 02/14/2007 | CN1913881A Preventive and/or therapeutic agent for chronic cerebral circulatory failure |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/14/2007 | CN1913879A Compositions and methods for treating diabetes |
| 02/14/2007 | CN1913878A Transdermal delivery of hormones without the need of penetration enhancers |
| 02/14/2007 | CN1913876A Drug-containing grains and solid preparation containing the grains |
| 02/14/2007 | CN1913875A Anionic hydrogel matrices with pH dependent modified release as drug carriers |
| 02/14/2007 | CN1913874A Particulate plant sterol compositions |
| 02/14/2007 | CN1913873A Medical product containing tiotropium incorporated in a waterproof container |
| 02/14/2007 | CN1913872A Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 02/14/2007 | CN1913871A Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
| 02/14/2007 | CN1913870A Flat system for using in the oral cavity |
| 02/14/2007 | CN1913868A Topical composition containing hyaluronic acid fragments and retinoid useful for cosmetic and medical dermatology |
| 02/14/2007 | CN1913778A Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 02/14/2007 | CN1912141A Identification of genes |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1911954A Glycyrrhizic acid derivative having amino acid, its preparation method and medicinal composition containing them |
| 02/14/2007 | CN1911953A Podophyllum kind compound and its use |
| 02/14/2007 | CN1911933A Oxygen, nitrogen heterocyclic naphthoyl imine kind compound and its bioapplication |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911928A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911925A 3,4-dihydro-III 2 benzopyran-1 ketone kind compound, its preparation method and use |
| 02/14/2007 | CN1911924A Extraction method of Nepal eagle tail isoflavone, its derivative and medicipal composition using said derivative as active component |
| 02/14/2007 | CN1911922A Compound separated from petroleum ether extract of glycyrrhiza legume bacteria strain CCNWGX022 fermentation liquid |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1911918A Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
| 02/14/2007 | CN1911449A Cholesterol phosphononucleoside analogue |
| 02/14/2007 | CN1911448A Zinc supplements based on cation exchange resin and its preparation method and use |
| 02/14/2007 | CN1911446A Process for producing nanoparticles of paclitaxel and albumin |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911437A Sobering-up beverage |
| 02/14/2007 | CN1911429A Medicine contg. irbesartan |
| 02/14/2007 | CN1911419A Medicinal composition for treating vertebrae lumbales hyperosteogeny |
| 02/14/2007 | CN1911417A Traditional Chinese medicine prescription for removing tragomaschalia and its prepn. method |
| 02/14/2007 | CN1911396A Method for controlling quality injection contg. traditional Chinese medicine |
| 02/14/2007 | CN1911395A Method for controlling quality of injection contg. traditional Chinese medicine |
| 02/14/2007 | CN1911392A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911391A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911390A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911376A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911375A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911374A Injection contg. traditional Chinese medicine, and its pren. method |
| 02/14/2007 | CN1911373A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911372A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911371A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911370A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911369A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911368A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911367A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911365A Injection contg. traditional Chinese medicine, and its prepn. method |
| 02/14/2007 | CN1911341A Traditional Chinese medicine prepn. for treating hyperosteogeny, and its external application prepn. |
| 02/14/2007 | CN1911331A Medicine prepn. for treating acne, and its prepn. method |
| 02/14/2007 | CN1911326A Oral medicine contg. donkey-hide gelatin and iron, and its prepn. method |
| 02/14/2007 | CN1911312A External application medicine for treating beri-beri |
| 02/14/2007 | CN1911311A Foaming medicine for vaginitis and cervical erosion and its prepn. method |
| 02/14/2007 | CN1911306A Ointment for treating beri-beri |
| 02/14/2007 | CN1911301A Compound medicine for treating acute/chronic gastroenteritis, and its prepn. method |
| 02/14/2007 | CN1911289A Compound medicine contg. musk |
| 02/14/2007 | CN1911282A Traditional Chinese medicine prepn. for treating lumbago |
| 02/14/2007 | CN1911277A Medicine for treating leukopenia |
| 02/14/2007 | CN1911276A Medicine for treating blood system disease |
| 02/14/2007 | CN1911274A Medicine for treating obstruction of qi in the chest, and its prodn. method |
| 02/14/2007 | CN1911246A Mongolian medicine for treating gynecologic inflammation, and its prepn. method |
| 02/14/2007 | CN1911238A Composite used for skin, and its application method |
| 02/14/2007 | CN1911237A Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 02/14/2007 | CN1911236A Application of doxycycline ad medicine for promoting cell proliferation |
| 02/14/2007 | CN1911235A Colon target prepn. contg. 5-aminosalicylic acid, and its prepn. method |
| 02/14/2007 | CN1911234A Reversing agent for drug-fast during treating tumor with multiple medicines |
| 02/14/2007 | CN1911233A Medicine composite contg. Moxabilli and antioxidant |